Real-World Outcomes of Chemoradiotherapy in Patients with Stage II/III Non-Small-Cell Lung Cancer in the Durvalumab Era: An Observational Study

ABSTRACT:

SUBMITTER: Muller J 

PROVIDER: S-EPMC12345666 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature